Tsewang Tashi

1.3k total citations
47 papers, 555 citations indexed

About

Tsewang Tashi is a scholar working on Genetics, Rheumatology and Molecular Biology. According to data from OpenAlex, Tsewang Tashi has authored 47 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 14 papers in Rheumatology and 12 papers in Molecular Biology. Recurrent topics in Tsewang Tashi's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Eosinophilic Disorders and Syndromes (12 papers) and Mast cells and histamine (9 papers). Tsewang Tashi is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Eosinophilic Disorders and Syndromes (12 papers) and Mast cells and histamine (9 papers). Tsewang Tashi collaborates with scholars based in United States, India and Spain. Tsewang Tashi's co-authors include Josef T. Prchal, Apar Kishor Ganti, Ibrahim Aldoss, Wilson I. Gonsalves, Jihyun Song, Felipe Lorenzo, Shanmuga Subbiah, Peter T. Silberstein, Soo Jin Kim and Chad D. Huff and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Tsewang Tashi

40 papers receiving 548 citations

Peers

Countries citing papers authored by Tsewang Tashi

Since Specialization

Citations

This map shows the geographic impact of Tsewang Tashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsewang Tashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsewang Tashi more than expected).

Fields of papers citing papers by Tsewang Tashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsewang Tashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsewang Tashi. The network helps show where Tsewang Tashi may publish in the future.

Co-authorship network of co-authors of Tsewang Tashi

This figure shows the co-authorship network connecting the top 25 collaborators of Tsewang Tashi. A scholar is included among the top collaborators of Tsewang Tashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsewang Tashi. Tsewang Tashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HARBOR: An Ongoing Phase 2/3 Study of Elenestinib in Patients With Indolent Systemic Mastocytosis 2025 ·Journal of Allergy and Clinical Immunology ·Mariana Castells, C. Bulaï Livideanu, Olivier Hermine, Vito Sabato, Marcus Maurer, Franziska Ruëff, Stéphane Barète, Laurence Bouillet, Jens Panse, (unknown), David González‐de‐Olano, (unknown), Robert Bird, Karin Hartmann, (unknown), Kevin He, Javier I. Muñoz‐González, Robyn M. Scherber, Tsewang Tashi, Mar Guilarte	1
2	Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients 2025 ·American Journal of Clinical Dermatology ·(unknown), Nathan A. Boggs, (unknown), Alejandro A. Gru, Tsewang Tashi, David A. Wada, Scott R. Florell, Melody C. Carter	1
3	PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia vera 2025 ·Annals of Hematology ·Abdulraheem Yacoub, Ghaith Abu‐Zeinah, Albert Qin, Tsewang Tashi, (unknown), Weichung Joe Shih, Oleh Zagrijtschuk, (unknown), Robert B. Geller, Norio Komatsu, Ruben A. Mesa, Harinder Gill	0
4	Prospective Ropeginterferon Alfa-2b Therapy in PV & ET Influences Prothrombotic, Inflammatory and Hypoxia Inducible Factors Activities and Effect of Concomitant DNMT3A Mutation 2024 ·Blood ·Jihyun Song, Soo‐Jin Kim, Young Wook Lim, (unknown), Amanda Smith, Aaron M. Swomley, Tsewang Tashi, Josef T. Prchal	0
5	Ultra-Sensitive KIT testing Uncovers Previously Undetected KIT mutations in Patients with Indolent Systemic Mastocytosis: Results from the Pioneer Trial 2024 ·Blood ·Deepti Radia, Tsewang Tashi, Iván Álvarez‐Twöse, Patrizia Bonadonna, Hanneke Oude Elberink, Sonia Cerquozzi, Tracy I. George, Guang Yang, Mark R. Rosenzweig, Huimin Lin, (unknown), Rachel Erlich, Jason Gotlib	4
6	Safety and Efficacy of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (AdvSM): Results from Part 1 of the Phase 2 Apex Trial 2023 ·Blood ·Pankit Vachhani, Tsewang Tashi, Gary J. Schiller, Stephanie J. Lee, Miguel Piris‐Villaespesa, Helena Pomares, C. Bulaï Livideanu, Jonathan Lambert, Anthony M. Hunter, Tracy I. George, Cristina Papayannidis, Khalid Shoumariyeh, (unknown), (unknown), (unknown), Hina Jolin, Rachael Easton, Vinod Pullarkat	3
7	Trends in overall mortality among US veterans with primary myelofibrosis 2023 ·BMC Cancer ·Tsewang Tashi, Jingbo Yu, (unknown), (unknown), Robyn M. Scherber, Shreekant Parasuraman	1
8	An unexpected cause of Cullen's sign: rupture of hepatocellular carcinoma 2022 ·British Journal of Hospital Medicine ·(unknown), Tsewang Tashi, (unknown)	1
9	Hematocrit, White Blood Cells, and Thrombotic Events in the Veteran Population With Polycythemia Vera 2022 ·Federal Practitioner ·Tsewang Tashi	0
10	Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers 2021 ·Blood Cancer Discovery ·Julie Feusier, Sasi Arunachalam, Tsewang Tashi, (unknown), (unknown), (unknown), Bryan E. Welm, Juan L. Rodríguez-Flores, (unknown), Lynn B. Jorde, Josef T. Prchal, Clinton C. Mason	23
11	Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia 2020 ·Blood Advances ·Radhika Gangaraju, Jihyun Song, Soo Jin Kim, Tsewang Tashi, Brandi Reeves, Krishna M. Sundar, Perumal Thiagarajan, Josef T. Prchal	51
12	Compassionate Use of Ropeginterferon-Alfa-2b/P1101 for Treatment of High Risk Polycythemia Vera and Essential Thrombocythemia Patients Previously Controlled on Pegylated Interferon-Alfa-2a/Pegasys® 2018 ·Blood ·Jeffrey A. Gilreath, Tsewang Tashi, Soo Jin Kim, (unknown), Josef T. Prchal	3
13	Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders 2017 ·Journal of Molecular Medicine ·Tsewang Tashi, N. Scott Reading, (unknown), Xu Zhang, Lorna G. Moore, Hao Hu, (unknown), Anna Shestakova, Felipe Lorenzo, Tatiana Burjanivová, Parvaiz A Koul, Prasenjit Guchhait, Carl T. Wittwer, Colleen G. Julian, Binal N. Shah, Chad D. Huff, Victor R. Gordeuk, Josef T. Prchal, Ri-Li Ge	58
14	Evolutionary history of Tibetans inferred from whole-genome sequencing 2017 ·PLoS Genetics ·Hao Hu, Nayia Petousi, Gustavo Glusman, Yao Yu, Ryan J. Bohlender, Tsewang Tashi, Jonathan M. Downie, Jared C. Roach, (unknown), Felipe Lorenzo, Alan R. Rogers, Mary E. Brunkow, Gianpiero L. Cavalleri, Leroy Hood, (unknown), Josef T. Prchal, Lynn B. Jorde, Peter A. Robbins, Tatum S. Simonson, Chad D. Huff	78
15	A Genome-Wide Search for Greek and Jewish Admixture in the Kashmiri Population 2016 ·PLoS ONE ·Jonathan M. Downie, Tsewang Tashi, Felipe Lorenzo, Julie Feusier, (unknown), Josef T. Prchal, Lynn B. Jorde, Parvaiz A Koul	8
16	High altitude genetic adaptation in Tibetans: No role of increased hemoglobin–oxygen affinity 2014 ·Blood Cells Molecules and Diseases ·Tsewang Tashi, (unknown), Parvaiz A Koul, Ricardo Amaru, (unknown), Felipe Lorenzo, Ri‐Li Ge, Josef T. Prchal	21
17	Assessment of prognostic factors after primary tumor resection in metastatic colon cancer patients: A Veteran's Affairs Central Cancer Registry (VACCR) analysis, 1995–2008 2012 ·Journal of Surgical Oncology ·Wilson I. Gonsalves, (unknown), Tsewang Tashi, Apar Kishor Ganti, Shanmuga Subbiah, Charles A. Ternent, Peter T. Silberstein	15
18	Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: A veterans' affairs central cancer registry (VACCR) database analysis 2011 ·Journal of Surgical Oncology ·Wilson I. Gonsalves, (unknown), Tsewang Tashi, Ibrahim Aldoss, Ashwin R. Sama, (unknown), (unknown), (unknown), Ramya Thota, Jairam Krishnamurthy, Xiang Fang, P. Townley, Apar Kishor Ganti, Shanmuga Subbiah, Peter T. Silberstein	25
19	Effect of Palliative Care Services on the Aggressiveness of End-of-Life Care in the Veteran's Affairs Cancer Population 2011 ·Journal of Palliative Medicine ·Wilson I. Gonsalves, Tsewang Tashi, Jairam Krishnamurthy, (unknown), (unknown), Ramya Thota, Ibrahim Aldoss, (unknown), (unknown), Neha Didwaniya, (unknown), Apar Kishor Ganti, Peter T. Silberstein, Shanmuga Subbiah	66
20	Seliciclib in malignancies 2009 ·Expert Opinion on Investigational Drugs ·Ibrahim Aldoss, Tsewang Tashi, Apar Kishor Ganti	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact